Anthony Iacco1, Adewunmi Adeyemo2, Thomas Riggs2, Randy Janczyk2. 1. Department of Surgery, William Beaumont Hospital System, Oakland University, Royal Oak, MI, USA. Electronic address: anthony.iacco@beaumont.edu. 2. Department of Surgery, William Beaumont Hospital System, Oakland University, Royal Oak, MI, USA.
Abstract
BACKGROUND: Complex ventral hernias remain a challenge. We present a study evaluating outcomes of complex ventral hernia repair using human-derived acellular dermal matrix (AlloDerm) and porcine-derived acellular dermal sheet (Permacol). METHODS: A retrospective review of 251 patients undergoing complex hernia repair was performed. Primary outcome was hernia recurrence; and secondary outcomes included early and late complications and mortality. RESULTS: Recurrence for Permacol versus AlloDerm was 32% versus 47% (P = .02). There was a difference in early complications (48% vs 30%, P = .007) and also late complications (30% vs 21%, P = .16) of Permacol versus AlloDerm. Overall survival was 85% for the Permacol group versus 78% for the AlloDerm group (P = .23). Recurrence for Permacol versus AlloDerm for underlay technique was 19% versus 22% and that for bridging technique was 44% versus 57%. CONCLUSION: There exists a high complication rate from both Permacol and AlloDerm in complex ventral hernia repair especially when used as a fascial bridge.
BACKGROUND: Complex ventral hernias remain a challenge. We present a study evaluating outcomes of complex ventral hernia repair using human-derived acellular dermal matrix (AlloDerm) and porcine-derived acellular dermal sheet (Permacol). METHODS: A retrospective review of 251 patients undergoing complex hernia repair was performed. Primary outcome was hernia recurrence; and secondary outcomes included early and late complications and mortality. RESULTS: Recurrence for Permacol versus AlloDerm was 32% versus 47% (P = .02). There was a difference in early complications (48% vs 30%, P = .007) and also late complications (30% vs 21%, P = .16) of Permacol versus AlloDerm. Overall survival was 85% for the Permacol group versus 78% for the AlloDerm group (P = .23). Recurrence for Permacol versus AlloDerm for underlay technique was 19% versus 22% and that for bridging technique was 44% versus 57%. CONCLUSION: There exists a high complication rate from both Permacol and AlloDerm in complex ventral hernia repair especially when used as a fascial bridge.
Authors: M Boules; A T Strong; R Corcelles; I N Haskins; R Ilie; C Wathen; D Froylich; G Sharma; J Rodriguez; S Rosenblatt; K El-Hayek; M Kroh Journal: Surg Endosc Date: 2017-09-20 Impact factor: 4.584
Authors: Giovanni Vennarecci; Gianluca Mascianà; Edoardo De Werra; Giovanni Battista Levi Sandri; Daniele Ferraro; Mirco Burocchi; Giovanni Tortorelli; Nicola Guglielmo; Giuseppe Maria Ettorre Journal: World J Transplant Date: 2017-02-24
Authors: F E E de Vries; J D Hodgkinson; J J M Claessen; O van Ruler; C A Leo; Y Maeda; O Lapid; M C Obdeijn; P J Tanis; W A Bemelman; J Constantinides; G B Hanna; J Warusavitarne; C Vaizey; M A Boermeester Journal: Hernia Date: 2020-02-20 Impact factor: 4.739
Authors: Ruth Kaufmann; Friedrich-Eckart Isemer; Christoph W Strey; Johannes Jeekel; Johan F Lange; Guido Woeste Journal: Langenbecks Arch Surg Date: 2020-04-22 Impact factor: 3.445